$4.76 Billion is the total value of Rock Springs Capital Management LP's 153 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 17.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGL | Buy | AGILON HEALTH INC | $185,436,000 | -34.7% | 7,075,000 | +1.1% | 3.90% | -30.5% |
| HUM | Buy | HUMANA INC | $133,089,000 | -0.6% | 342,000 | +13.1% | 2.80% | +5.7% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $133,086,000 | +16.0% | 200,000 | +6.5% | 2.80% | +23.4% |
| PODD | Buy | INSULET CORP | $124,369,000 | +10.8% | 437,566 | +7.0% | 2.62% | +17.9% |
| ISRG | INTUITIVE SURGICAL INC | $119,298,000 | +8.1% | 120,000 | 0.0% | 2.51% | +15.0% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $117,968,000 | -16.8% | 2,556,179 | -0.7% | 2.48% | -11.6% |
| ZLAB | Buy | ZAI LAB LTDadr | $113,584,000 | -36.7% | 1,077,750 | +6.3% | 2.39% | -32.7% |
| IDXX | IDEXX LABS INC | $111,942,000 | -1.5% | 180,000 | 0.0% | 2.35% | +4.8% | |
| HCA | HCA HEALTHCARE INC | $109,224,000 | +17.4% | 450,000 | 0.0% | 2.30% | +24.9% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $100,849,000 | +2.1% | 1,051,500 | +3.6% | 2.12% | +8.6% |
| ARGX | ARGENX SEsponsored adr | $95,130,000 | +0.3% | 315,000 | 0.0% | 2.00% | +6.7% | |
| NVAX | NOVAVAX INC | $94,326,000 | -2.4% | 455,000 | 0.0% | 1.98% | +3.9% | |
| UNH | UNITEDHEALTH GROUP INC | $93,778,000 | -2.4% | 240,000 | 0.0% | 1.97% | +3.8% | |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $90,642,000 | -3.1% | 2,445,155 | +2.1% | 1.91% | +3.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $87,353,000 | +22.8% | 849,659 | +5.0% | 1.84% | +30.7% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $76,897,000 | +31.4% | 702,000 | +12.3% | 1.62% | +39.8% |
| FRPT | Buy | FRESHPET INC | $75,198,000 | -8.9% | 527,000 | +4.0% | 1.58% | -3.1% |
| NVTA | Buy | INVITAE CORP | $74,084,000 | -4.6% | 2,605,829 | +13.2% | 1.56% | +1.5% |
| NVRO | Buy | NEVRO CORP | $73,983,000 | -16.0% | 635,700 | +19.7% | 1.56% | -10.6% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $72,252,000 | +63.0% | 801,109 | +72.3% | 1.52% | +73.4% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $68,458,000 | +3.6% | 3,803,232 | +1.1% | 1.44% | +10.2% |
| EW | EDWARDS LIFESCIENCES CORP | $65,888,000 | +9.3% | 582,000 | 0.0% | 1.38% | +16.3% | |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $63,756,000 | +107.6% | 400,000 | +71.3% | 1.34% | +120.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $62,540,000 | +21.3% | 353,514 | +10.8% | 1.32% | +29.0% |
| PHR | Buy | PHREESIA INC | $59,849,000 | +1.7% | 970,000 | +1.0% | 1.26% | +8.2% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $58,720,000 | +15.5% | 311,000 | +3.7% | 1.24% | +22.9% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $58,125,000 | +62.0% | 1,875,000 | +10.4% | 1.22% | +72.4% |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $56,000,000 | -10.0% | 1,000,000 | -2.4% | 1.18% | -4.2% |
| EXAS | EXACT SCIENCES CORP | $54,407,000 | -23.2% | 570,000 | 0.0% | 1.14% | -18.3% | |
| PRTA | Sell | PROTHENA CORP PLC | $50,604,000 | +3.6% | 710,430 | -25.2% | 1.06% | +10.3% |
| TFX | TELEFLEX INCORPORATED | $48,952,000 | -6.3% | 130,000 | 0.0% | 1.03% | -0.3% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $47,943,000 | +8.8% | 391,917 | +1.4% | 1.01% | +15.7% |
| ARVN | Sell | ARVINAS INC | $47,459,000 | -1.6% | 577,500 | -7.8% | 1.00% | +4.7% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $47,217,000 | +81.2% | 1,600,589 | +57.4% | 0.99% | +92.8% |
| SWAV | SHOCKWAVE MED INC | $45,294,000 | +8.5% | 220,000 | 0.0% | 0.95% | +15.4% | |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $45,284,000 | +3.1% | 710,000 | +1.4% | 0.95% | +9.7% |
| VERV | VERVE THERAPEUTICS INC | $45,253,000 | -22.0% | 962,826 | 0.0% | 0.95% | -17.1% | |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $43,052,000 | +41.7% | 732,927 | +17.0% | 0.90% | +50.6% |
| HCAT | Buy | HEALTH CATALYST INC | $42,509,000 | -2.4% | 850,000 | +8.3% | 0.89% | +3.8% |
| SGEN | SEAGEN INC | $42,450,000 | +7.6% | 250,000 | 0.0% | 0.89% | +14.5% | |
| PEN | PENUMBRA INC | $39,309,000 | -2.8% | 147,500 | 0.0% | 0.83% | +3.5% | |
| ACCD | Buy | ACCOLADE INC | $38,923,000 | +7.8% | 923,000 | +38.8% | 0.82% | +14.6% |
| EHC | ENCOMPASS HEALTH CORP | $37,520,000 | -3.8% | 500,000 | 0.0% | 0.79% | +2.3% | |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $36,298,000 | +66.5% | 1,496,817 | +0.2% | 0.76% | +77.0% |
| BAX | New | BAXTER INTL INC | $36,194,000 | – | 450,000 | +100.0% | 0.76% | – |
| New | WARBY PARKER INC | $34,483,000 | – | 650,000 | +100.0% | 0.72% | – | |
| GRPH | Sell | GRAPHITE BIO INC | $34,037,000 | -48.5% | 2,076,710 | -3.5% | 0.72% | -45.2% |
| XENT | INTERSECT ENT INC | $33,184,000 | +59.2% | 1,220,000 | 0.0% | 0.70% | +69.4% | |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $32,368,000 | +26.7% | 350,000 | +6.5% | 0.68% | +34.9% |
| ALLK | ALLAKOS INC | $32,365,000 | +24.0% | 305,706 | 0.0% | 0.68% | +32.0% | |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $30,390,000 | +15.4% | 1,525,623 | +0.1% | 0.64% | +22.6% |
| CVET | Buy | COVETRUS INC | $29,450,000 | -25.0% | 1,623,500 | +11.6% | 0.62% | -20.2% |
| New | IMMUNEERING CORP | $28,935,000 | – | 1,089,816 | +100.0% | 0.61% | – | |
| SRRA | Buy | SIERRA ONCOLOGY INC | $28,803,000 | +45.2% | 1,313,997 | +29.0% | 0.61% | +54.6% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $28,485,000 | -26.3% | 3,020,702 | +6.2% | 0.60% | -21.6% |
| CYTOKINETICS INCnote 4.000%11/1 | $28,316,000 | +70.9% | 8,000,000 | 0.0% | 0.60% | +82.0% | ||
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $27,469,000 | +66.0% | 1,429,921 | -14.9% | 0.58% | +76.8% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $26,306,000 | +54.8% | 750,307 | -5.2% | 0.55% | +64.6% |
| IRTC | IRHYTHM TECHNOLOGIES INC | $26,235,000 | -11.7% | 448,000 | 0.0% | 0.55% | -6.0% | |
| DXCM | Buy | DEXCOM INC | $25,429,000 | +30.6% | 46,500 | +2.0% | 0.54% | +39.0% |
| LUNG | Buy | PULMONX CORP | $25,186,000 | -3.7% | 700,000 | +18.1% | 0.53% | +2.5% |
| GH | GUARDANT HEALTH INC | $25,002,000 | +0.7% | 200,000 | 0.0% | 0.53% | +7.1% | |
| LFST | Buy | LIFESTANCE HEALTH GROUP INC | $24,469,000 | -41.4% | 1,687,500 | +12.5% | 0.51% | -37.8% |
| CGEM | CULLINAN ONCOLOGY INC | $24,283,000 | -12.4% | 1,075,912 | 0.0% | 0.51% | -6.8% | |
| ABOS | New | ACUMEN PHARMACEUTICALS INC | $23,467,000 | – | 1,579,191 | +100.0% | 0.49% | – |
| ABCM | Buy | ABCAM PLCads | $23,262,000 | +11.3% | 1,147,588 | +4.6% | 0.49% | +18.4% |
| New | AADI BIOSCIENCES INC | $22,459,000 | – | 764,701 | +100.0% | 0.47% | – | |
| AMRN | AMARIN CORP PLCspons adr new | $22,032,000 | +16.4% | 4,320,000 | 0.0% | 0.46% | +23.8% | |
| New | ICOSAVAX INC | $21,725,000 | – | 734,215 | +100.0% | 0.46% | – | |
| CNMD | CONMED CORP | $21,260,000 | -4.8% | 162,500 | 0.0% | 0.45% | +1.4% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $20,945,000 | -18.1% | 262,500 | 0.0% | 0.44% | -12.9% | |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $20,863,000 | -16.7% | 1,649,248 | +1.9% | 0.44% | -11.3% |
| NVCR | NOVOCURE LTD | $20,330,000 | -47.6% | 175,000 | 0.0% | 0.43% | -44.3% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $19,593,000 | -7.4% | 253,500 | 0.0% | 0.41% | -1.4% | |
| OSH | Buy | OAK STR HEALTH INC | $18,756,000 | -14.6% | 441,000 | +17.6% | 0.39% | -9.2% |
| EPZM | Buy | EPIZYME INC | $18,401,000 | -26.5% | 3,593,885 | +19.3% | 0.39% | -21.8% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $17,766,000 | -18.3% | 900,000 | -2.2% | 0.37% | -13.0% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $17,400,000 | -15.7% | 4,793,400 | +0.8% | 0.37% | -10.3% |
| SPRO | Sell | SPERO THERAPEUTICS INC | $17,334,000 | +28.6% | 941,543 | -2.5% | 0.36% | +36.8% |
| GOSSAMER BIO INCnote 5.000% 6/0 | $16,253,000 | +29.1% | 15,573,000 | 0.0% | 0.34% | +37.3% | ||
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $15,937,000 | +24.2% | 315,218 | +0.8% | 0.34% | +31.9% |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $15,601,000 | – | 1,295,225 | +100.0% | 0.33% | – |
| KURA | Buy | KURA ONCOLOGY INC | $15,405,000 | -9.5% | 822,500 | +0.7% | 0.32% | -3.9% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $14,805,000 | -10.1% | 469,560 | +4.3% | 0.31% | -4.6% |
| ANAB | Buy | ANAPTYSBIO INC | $14,532,000 | +4.7% | 535,832 | +0.1% | 0.31% | +11.7% |
| RXDX | Buy | PROMETHEUS BIOSCIENCES INC | $14,466,000 | -1.2% | 610,136 | +2.4% | 0.30% | +5.2% |
| BHG | Sell | BRIGHT HEALTH GROUP INC | $14,402,000 | -64.7% | 1,765,000 | -25.7% | 0.30% | -62.4% |
| LPTX | New | LEAP THERAPEUTICS INC | $14,068,000 | – | 3,508,270 | +100.0% | 0.30% | – |
| NKTX | Buy | NKARTA INC | $13,993,000 | -11.3% | 503,148 | +1.0% | 0.29% | -5.8% |
| BMEA | BIOMEA FUSION INC | $13,952,000 | -23.3% | 1,165,582 | 0.0% | 0.29% | -18.6% | |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $13,572,000 | +33.3% | 613,269 | -22.0% | 0.28% | +41.8% |
| MGNX | Buy | MACROGENICS INC | $13,440,000 | +9.8% | 641,816 | +40.8% | 0.28% | +16.9% |
| VINC | New | VINCERX PHARMA INC | $12,941,000 | – | 800,295 | +100.0% | 0.27% | – |
| FULC | New | FULCRUM THERAPEUTICS INC | $12,844,000 | – | 455,290 | +100.0% | 0.27% | – |
| WST | Buy | WEST PHARMACEUTICAL SVSC INC | $12,736,000 | +24.4% | 30,000 | +5.3% | 0.27% | +32.7% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $12,710,000 | -3.1% | 568,701 | +7.6% | 0.27% | +3.1% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $12,540,000 | +14.2% | 1,577,296 | 0.0% | 0.26% | +21.7% | |
| OLK | Buy | OLINK HLDG ABsponsored ads | $12,246,000 | -16.3% | 505,000 | +18.8% | 0.26% | -11.1% |
| RCKT | ROCKET PHARMACEUTICALS INC | $12,054,000 | -32.5% | 403,270 | 0.0% | 0.25% | -28.3% | |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $11,696,000 | -18.8% | 4,832,978 | +6.4% | 0.25% | -13.7% |
| APLT | APPLIED THERAPEUTICS INC | $11,648,000 | -20.1% | 701,680 | 0.0% | 0.24% | -14.9% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $11,321,000 | +72.0% | 2,189,788 | +41.7% | 0.24% | +83.1% |
| PRLD | Sell | PRELUDE THERAPEUTICS INC | $11,324,000 | +3.4% | 362,359 | -5.2% | 0.24% | +10.2% |
| TRILLIUM THERAPEUTICS INC | $11,036,000 | +81.0% | 628,500 | 0.0% | 0.23% | +93.3% | ||
| OHPAU | ORION ACQUISITION CORPunit 02/19/2026 | $9,895,000 | -0.3% | 1,000,000 | 0.0% | 0.21% | +6.1% | |
| INZY | Buy | INOZYME PHARMA INC | $9,852,000 | -31.2% | 850,015 | +1.2% | 0.21% | -26.9% |
| SPRB | Buy | SPRUCE BIOSCIENCES INC | $9,722,000 | -46.0% | 1,617,601 | +0.8% | 0.20% | -42.7% |
| FOLD | AMICUS THERAPEUTICS INC | $9,669,000 | -0.9% | 1,012,506 | 0.0% | 0.20% | +5.2% | |
| NRIX | Buy | NURIX THERAPEUTICS INC | $9,541,000 | +14.0% | 318,450 | +1.0% | 0.20% | +21.8% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $8,933,000 | +5.0% | 376,439 | +0.7% | 0.19% | +11.9% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $8,910,000 | -16.4% | 583,100 | +1.9% | 0.19% | -11.4% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $8,781,000 | -8.9% | 688,149 | +0.8% | 0.18% | -2.6% |
| RPHM | Buy | RENEO PHARMACEUTICALS INC | $8,517,000 | -19.1% | 1,143,185 | +1.3% | 0.18% | -13.9% |
| GMDA | Buy | GAMIDA CELL LTD | $8,418,000 | -37.7% | 2,147,400 | +1.9% | 0.18% | -33.7% |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $8,092,000 | -28.3% | 1,665,014 | +0.6% | 0.17% | -23.8% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $7,995,000 | -32.7% | 612,180 | +1.0% | 0.17% | -28.5% |
| FSTX | F-STAR THERAPEUTICS INC | $7,717,000 | -14.8% | 1,054,232 | 0.0% | 0.16% | -9.5% | |
| CGEN | Buy | COMPUGEN LTDord | $7,664,000 | -25.2% | 1,283,790 | +3.8% | 0.16% | -20.3% |
| KNTE | Buy | KINNATE BIOPHARMA INC | $7,665,000 | -0.7% | 332,986 | +0.4% | 0.16% | +5.2% |
| FUSN | FUSION PHARMACEUTICALS INC | $7,511,000 | -2.0% | 948,327 | 0.0% | 0.16% | +4.6% | |
| EAR | Sell | EARGO INC | $6,562,000 | -88.7% | 975,000 | -32.8% | 0.14% | -87.9% |
| FATE | Buy | FATE THERAPEUTICS INC | $6,520,000 | +7.3% | 110,000 | +57.1% | 0.14% | +14.2% |
| STTK | SHATTUCK LABS INC | $6,389,000 | -29.7% | 313,499 | 0.0% | 0.13% | -25.6% | |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $5,734,000 | -16.4% | 1,843,764 | 0.0% | 0.12% | -11.0% | |
| ATHA | Sell | ATHIRA PHARMA INC | $5,180,000 | -32.4% | 552,252 | -26.2% | 0.11% | -27.8% |
| TBPH | THERAVANCE BIOPHARMA INC | $5,088,000 | -49.0% | 687,500 | 0.0% | 0.11% | -45.7% | |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $4,907,000 | -25.7% | 334,050 | +0.6% | 0.10% | -21.4% |
| EDAP | EDAP TMS S Asponsored adr | $4,855,000 | -10.0% | 760,900 | 0.0% | 0.10% | -4.7% | |
| ATAI | Buy | ATAI LIFE SCIENCES NV | $4,698,000 | -19.4% | 317,628 | +0.8% | 0.10% | -13.9% |
| GRTX | GALERA THERAPEUTICS INC | $4,603,000 | -17.6% | 568,252 | 0.0% | 0.10% | -11.8% | |
| TPST | TEMPEST THERAPEUTICS INC | $4,488,000 | +29.4% | 310,161 | 0.0% | 0.09% | +36.2% | |
| EPIX | Buy | ESSA PHARMA INC | $4,064,000 | -71.7% | 508,044 | +1.0% | 0.08% | -70.1% |
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $3,896,000 | -25.5% | 3,819,402 | +0.8% | 0.08% | -20.4% |
| INNV | Sell | INNOVAGE HLDG CORP | $3,470,000 | -82.0% | 525,000 | -41.8% | 0.07% | -80.8% |
| IMRA | New | IMARA INC | $3,383,000 | – | 829,102 | +100.0% | 0.07% | – |
| TRAVERE THERAPEUTICS INCnote 2.500% 9/1 | $3,276,000 | +18.5% | 3,250,000 | 0.0% | 0.07% | +25.5% | ||
| BLSA | BCLS ACQUISITION CORP | $3,078,000 | -5.4% | 309,000 | 0.0% | 0.06% | +1.6% | |
| BCEL | ATRECA INC | $2,865,000 | -26.9% | 459,830 | 0.0% | 0.06% | -22.1% | |
| NUVB | Sell | NUVATION BIO INC | $2,352,000 | +4.6% | 236,609 | -2.0% | 0.05% | +11.4% |
| PSTX | POSEIDA THERAPEUTICS INC | $2,112,000 | -27.2% | 289,754 | 0.0% | 0.04% | -22.8% | |
| FSII | FS DEVELOPMENT CORP II | $2,083,000 | -0.3% | 209,332 | 0.0% | 0.04% | +7.3% | |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $2,046,000 | -1.3% | 206,000 | 0.0% | 0.04% | +4.9% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,050,000 | -2.4% | 206,000 | 0.0% | 0.04% | +2.4% | |
| PHICU | POPULATION HEALTH INVS CO INunit 99/99/9999 | $2,011,000 | -1.5% | 201,044 | 0.0% | 0.04% | +5.0% | |
| JYAC | JIYA ACQUISITION CORP | $2,010,000 | -2.0% | 206,200 | 0.0% | 0.04% | +2.4% | |
| HLXA | HELIX ACQUISITION CORP | $1,537,000 | -3.9% | 154,500 | 0.0% | 0.03% | 0.0% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,370,000 | -1.7% | 1,500,000 | 0.0% | 0.03% | +3.6% | ||
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,391,000 | -2.7% | 1,500,000 | 0.0% | 0.03% | +3.6% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,336,000 | -0.8% | 1,000,000 | 0.0% | 0.03% | +3.7% | ||
| PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $1,038,000 | -5.1% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| APLS | New | APELLIS PHARMACEUTICALS INC | $872,000 | – | 26,458 | +100.0% | 0.02% | – |
| NEVRO CORPnote 2.750% 4/0 | $675,000 | -22.1% | 500,000 | 0.0% | 0.01% | -17.6% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $343,000 | -1.4% | 134,028 | 0.0% | 0.01% | 0.0% | |
| ARPO | Exit | AERPIO PHARMACEUTICALS INC | $0 | – | -133,375 | -100.0% | -0.00% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -693,542 | -100.0% | -0.13% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -312,687 | -100.0% | -0.16% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -247,200 | -100.0% | -0.16% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INCcall | $0 | – | -157,900 | -100.0% | -0.20% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -165,000 | -100.0% | -0.22% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -3,258,144 | -100.0% | -0.30% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -693,266 | -100.0% | -0.38% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,000,000 | -100.0% | -0.48% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -650,000 | -100.0% | -0.52% | – |
| PPD | Exit | PPD INC | $0 | – | -675,000 | -100.0% | -0.62% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -800,000 | -100.0% | -0.68% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -113,500 | -100.0% | -0.78% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -5,248,829 | -100.0% | -0.79% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -200,000 | -100.0% | -1.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.